Authors:
MCGUIRE D
GARRISON L
ARMON C
BAROHN R
BRYAN W
MILLER R
PARRY G
PETAJAN J
ROSS M
ALTERNUS P
AMOX D
ASHBURN C
AULENBACHER D
BLASUCCI L
BROWN E
CAULKINS M
CAROZZA C
DAO H
DAVIS L
DRISCOLL T
FRIERSON L
FUQUA P
GARDNER H
GOLBESKY B
GOOD B
GRAVES J
HARSTOCK L
HAWKINS C
HERNANDEZ R
ITURRIAGA E
KRES J
LAURENZI B
LEE E
LEYDE D
MEHAGIAN M
MOSES D
NASH J
NORWOOD N
PARSONS J
PEARMAIN J
RATLIFFWALKER D
RIGHTMYER D
RIZZI V
SMITH B
SOLIMAN M
VOLINTINE L
WARDER J
WERNER J
WOLF S
Citation: D. Mcguire et al., RELATIONSHIP OF THE TUFTS QUANTITATIVE NEUROMUSCULAR EXAM (TQNE) AND THE SICKNESS IMPACT PROFILE (SIP) IN MEASURING PROGRESSION OF ALS, Neurology, 46(5), 1996, pp. 1442-1444
Authors:
MILLER RG
GELINAS D
MOORE D
MENDOZA M
QUIEN A
YOUNG L
ARMON C
LINDA L
BAROHN R
BRYAN W
BROMBERG M
PETAJAN J
NEVILLE H
RINGEL S
PARRY G
RAVITS J
ROSS M
LEIDERMAN D
Citation: Rg. Miller et al., A PLACEBO-CONTROLLED TRIAL OF GABAPENTIN IN AMYOTROPHIC-LATERAL-SCLEROSIS, Neurology, 46(2), 1996, pp. 64002-64002
Authors:
MCGUIRE D
GARRISON L
ARMON C
BAROHN R
BRYAN W
MILLER R
PARRY G
PETAJAN J
Citation: D. Mcguire et al., TUFTS QUANTITATIVE NEUROMUSCULAR EXAMINATION - HIGH CORRELATION WITH THE SICKNESS IMPACT PROFILE IN MEASURING PROGRESSION OF AMYOTROPHIC-LATERAL-SCLEROSIS, Annals of neurology, 38(2), 1995, pp. 336-337
Authors:
ROSS MA
PARRY GJ
MILLER RG
ARMON C
BAROHN R
BRYAN WW
PETAJAN J
STROMATT S
Citation: Ma. Ross et al., EVALUATION OF AMYOTROPHIC-LATERAL-SCLEROSIS DIAGNOSTIC-CRITERIA (ALSDC) FOR A CONTROLLED TRIAL OF RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR (RHCNTF), Neurology, 45(4), 1995, pp. 280-280
Authors:
MILLER RG
ARMON C
BAROHN R
BRYAN W
GOODPASTURE J
PARRY G
PETAJAN J
ROSS M
STROMATT S
Citation: Rg. Miller et al., A CONTROLLED TRIAL OF RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR (RHCNTF) IN AMYOTROPHIC-LATERAL-SCLEROSIS (ALS), Neurology, 45(4), 1995, pp. 281-281
Authors:
ABDALLAH HY
BLOEDOW DC
BRYAN W
DIETZ M
PETAJAN J
SMITH S
MUNSAT T
MILLER RG
Citation: Hy. Abdallah et al., PHARMACOKINETICS (PK) OF RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR (RHCNTF) IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS (ALS), Neurology, 45(4), 1995, pp. 281-281
Authors:
SYNDULKO K
TOURTELLOTTE WW
CONRAD AJ
IZQUIERDO G
BELENDUK G
KASPER B
KLATZMAN D
MIETLOWSKI W
SOLCH S
FRANKLIN G
BURKS J
NELSON L
WANGAARD C
MCFARLAND H
GOODMAN A
MCFARLIN D
KREBS H
MALONI H
DEBRONOZO J
SCHEINBERG L
TRAUGOTT U
AISEN M
ROBBINS K
SIBLEY W
LAGUNA J
LAGUNA J
TROTTER J
CLIFORD D
SMITH L
MCINNIS J
ARNASON B
ROOS R
REDER A
ANTEL J
AGUIS M
MARTIA R
HURWITZ B
GREENBURG S
FREDANE L
HERBSTREITH R
HURWITZ J
JOHNSON K
PANITCH H
KOSKI CL
FISHMAN P
HALEY S
PETAJAN J
BRAY P
ROSE J
THURMAN D
GALSTER W
ELLISON G
MYERS L
NEWTON L
WOLINSKY J
SEARS ES
NATH A
WEISBRODT C
KASTRUKOFF LF
OGER JJ
PATY D
BAUMHEFNER RW
Citation: K. Syndulko et al., TRANS-BLOOD-BRAIN-BARRIER ALBUMIN LEAKAGE AND COMPARISONS OF INTRATHECAL IGG SYNTHESIS CALCULATIONS IN MULTIPLE-SCLEROSIS PATIENTS, Journal of neuroimmunology, 46(1-2), 1993, pp. 185-192
Authors:
OCHOA JL
SUBBARAO J
PETAJAN J
ANDARY M
GREEN J
JACOBS S
DOWNEY J
STEWART J
HENING W
HALLETT M
KATIMS J
SRIDHARA C
JACOME D
BURKE D
PALERMO F
HAGBARTH KE
HOROWITZ S
SUMNER A
AMASSIAN V
Citation: Jl. Ochoa et al., ESSENCE, INVESTIGATION, AND MANAGEMENT OF NEUROPATHIC PAINS - HOPES FROM ACKNOWLEDGMENT OF CHAOS - DISCUSSION, Muscle & nerve, 16(10), 1993, pp. 1066-1079